Do pharmaceutical companies have an obligation to develop and produce vaccines for diseases that exist primarily in poorer countries?

Pharmaceutical companies have a moral obligation to develop and produce vaccines for diseases prevalent in poorer countries, as these populations often lack access to essential healthcare resources. While the primary goal of these companies is to generate profit, ethical considerations and global health equity should drive their efforts in addressing health disparities. Additionally, partnerships with governments and non-profit organizations can facilitate vaccine development and distribution to underserved regions. Ultimately, fulfilling this obligation can contribute to global health security and social responsibility.